Re: Subsequent Event for Jan. 10Q

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BUSHleague

Rank: Treasurer [?]

Points: 7397 [?]

Votes: 86 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Subsequent Event for Jan. 10Q

in response to

Re: Subsequent Event for Jan. 10Q

aimgator

posted on Dec 18, 2007 10:37AM

Not quite. A material event subsequent to the quarter end (in this instance the qtr ending Nov) would need to be reported on as a subsequent event in that quarter's filing, thus we should see information in January's 10Q. To what degree I do not know, but in the past they indicated an aggregate amount of licensing deals that had been signed in the weeks after the quarter end but prior to the filing.